Besides, the specificity and efficacy of the prostate stem cell antigen (PSCA)- and MUC1-targeting chimeric antigen receptor (CAR) T cells against NSCLC cell lines in vitro were confirmed [26]. The gene discussed is MUC1; the disease is non-small cell lung carcinoma.